Home » Bristol-Myers, AstraZeneca Expand Diabetes Alliance
Bristol-Myers, AstraZeneca Expand Diabetes Alliance
Bristol-Myers Squibb Company and AstraZeneca have announced the completion of the acquisition of Amylin Pharmaceuticals by Bristol-Myers Squibb.
Pharmaceutical Business Review
Pharmaceutical Business Review
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May